Securian Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
Securian Asset Management's JAZZ Position: Q1 2026 in Review
Securian Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 4,443 shares worth $840K. The position accounts for 0.03% of the portfolio, ranked #389.
Securian Asset Management first reported a position in JAZZ in Q3 2020 and has held it in 23 quarters since. The position peaked at $981K in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Securian Asset Management held 4,443 shares of Jazz Pharmaceuticals worth $840K as of Q1 2026.
- Securian Asset Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
- Jazz Pharmaceuticals made up 0.03% of Securian Asset Management's portfolio in Q1 2026, its #389 holding.
- Securian Asset Management first reported a position in Jazz Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
- Securian Asset Management's Jazz Pharmaceuticals position peaked at $981K in Q2 2021.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Securian Asset Management's 13F filing for Q1 2026, filed 1 May 2026.